XML 25 R17.htm IDEA: XBRL DOCUMENT v3.22.2.2
Warrant liability
6 Months Ended
Jun. 30, 2022
Text block [abstract]  
Warrant liability
12. Warrant liability
 
    
June 30,
2022
£’000
    
June 30,
   2021 £’000  
 
At January 1
  
 
8,336
 
  
 
50,775
 
    
 
 
    
 
 
 
Warrants exercised
     —          (2,400
Fair value changes during the period
     (1,210      (14,364
    
 
 
    
 
 
 
At June 30
  
 
7,126
 
  
 
34,011
 
    
 
 
    
 
 
 
 
 
  
June 30,
2022
£’000
 
  
December 31,
2021

£’000
 
Current
     6,904        —    
Non-current
     222        8,336  
    
 
 
    
 
 
 
Total
  
 
7,126
 
  
 
8,336
 
    
 
 
    
 
 
 
The change in fair value of the warrant liability represents an unrealized gain for the six months ended June 30, 2022 and for the six months ended June 30, 2021.
Warrants - private placement
As a part of the private placement transaction on June 3, 2020, the participating investors received conditional warrants entitling them to subscribe for an aggregate of 161,048,366 ordinary shares in the Company. The warrants were conditional on certain resolutions being passed at the Company’s general meeting on June 30, 2020. On the passing of the resolutions, the warrants entitled the investors to subscribe for ordinary shares at an exercise price of £0.348 per warrant and are exercisable until June 2023. The warrants are classified as liabilities as the Company does not have an unconditional right to avoid redeeming the instruments for cash. The fair value of the warrant liability was £6.9 million as of June 30, 2022 (£8.0 million as of December 31, 2021). The change in the fair value of £1.1 million was recognized as a gain in the
condensed 
consolidated statement of comprehensive
(loss)/
income. In the six months ended June 30, 2022, 
no
 warrants were exercised.
Warrants – bank loan
As of June 30, 2022 and December 31, 2021, the former lenders of the Company have warrants outstanding to purchase a total of 1,243,908 ordinary shares at an exercise price of £2.95 per share
exercisable until August 2027 
and a total of 1,243,908 ordinary shares at an exercise price of $0.4144 per share
 
exercisable until October 2028. 
At June 30, 2022, the fair value of these warrants were £0.2 million (December 31, 2021: £0.3 million). The change in the fair value of £0.1 million was recognized as a gain in the
condensed 
consolidated statement of comprehensive
(loss)/
income. There were no warrants exercised during the six months ended June 30, 2022.
Total outstanding warrants
At June 30, 2022, a total of 147,431,351 warrants are outstanding. The warrants outstanding are equivalent to 25% of the ordinary share capital of the Company.
The following table lists the weighted average inputs to the models used for the fair value of warrants:
 
    
June 30, 2022
    
December 31, 2021
 
Expected volatility (%)
     116        75  
Risk-free interest rate (%)
     2.4        0.9  
Expected life of share options (years)
     1.0        1.5  
Market price of ADS($)
     1.12        1.60  
Model used
    
Black-Scholes
      
Black-Scholes
 
Volatility was estimated by reference to the one year historical volatility of the historical share price of the Company.